Filing Details

Accession Number:
0001140361-15-011273
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-11 12:11:24
Reporting Period:
2015-03-10
Filing Date:
2015-03-11
Accepted Time:
2015-03-11 12:11:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874716 Idexx Laboratories Inc IDXX In Vitro & In Vivo Diagnostic Substances (2835) 010393723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1184157 T William End One Idexx Drive
Westbrook ME 04092
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-03-10 3,500 $150.89 25,827 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $150.75 to $151.16, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.